Kenneth A. Stauderman - 25 Jul 2025 Form 4 Insider Report for CalciMedica, Inc. (CALC)

Reporting relationship: Chief Scientific Officer
Issuer ticker: CALC
Reported as of: 25 Jul 2025
Net transaction value: +$310
SEC form: 4
Accepted by SEC: 29 Jul 2025, 16:52:29 UTC
Prior SEC filing: 02 Jul 2025
Next SEC filing: 07 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ John Dunn, Esq., Attorney-in-Fact

Key filing fact

Kenneth A. Stauderman filed Form 4 for CalciMedica, Inc. (CALC) on 29 Jul 2025.

Key facts

This page summarizes Kenneth A. Stauderman's Form 4 filing for CalciMedica, Inc. (CALC).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 29 Jul 2025, 16:52.

Change

Previous filing in this sequence was filed on 02 Jul 2025.
Current net transaction value: +$310.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001969388 Primary reporting owner

Stauderman Kenneth A.

Relationship: Chief Scientific Officer
Address: CALCIMEDICA, INC., 505 COAST S. BLVD. #307, LA JOLLA
Signature: /s/ John Dunn, Esq., Attorney-in-Fact
Signature date: 29 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CALC transaction

Common Stock

Sale

Transaction value: $3,650
Shares: -1,000
Change %: -100%
Price: $3.65
Shares after: 0
Date: 25 Jul 2025
Ownership: By Spouse
Footnotes: F1

CALC transaction

Common Stock

Purchase

Transaction value: $3,960
Shares: +1,000
Change %: +8.4%
Price: $3.96
Shares after: 12,944
Date: 28 Jul 2025
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The sale of the common stock of CalciMedica, Inc. (the "Issuer") by the spouse of the reporting person reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the purchase of 1,000 shares of the Issuer's common stock by the reporting person's spouse at a price of $1.85 per share on July 1, 2025. The reporting person has agreed to pay to the Issuer upon settlement of the sale, $1,799.83, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.